Treatment of Burns: Established and Novel Technologies

Cambiaso‐Daniel, Janos; Boukovalas, Stefanos; Boson, Alexis L.; Branski, Ludwik K.; Kamolz, Lars‐Peter

doi:10.1007/978-3-030-18940-2_37

Cited by 1 publication

(1 citation statement)

References 146 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Partial thickness burns were treated conservatively by wound debridement followed by local use of drugs such as an ointment or dressing sheets [3]. However, this method of treatment can be very painful for a patient and can cause stress disorders [4].…”

Section: Introductionmentioning

confidence: 99%

Therapeutic Treatment of 2A Grade Burns with Decellularized Bovine Peritoneum as a Xenograft: Multicenter Randomized Clinical Trial

et al. 2022

View full text Add to dashboard Cite

Background and Objectives: Homogeneous and xenogenic bioengineering structures are actively used as wound coatings in treatment of burns and have already shown their effectiveness. Nevertheless, the disadvantage of such dressings is their high cost. This issue is particularly challenging for developing countries in which the incidence of burns is the highest one. With such needs taken into account, the research team developed and clinically tested a new wound coating based on decellularized bovine peritoneum (DBP). Materials and Methods: A multicenter randomized clinical trial was conducted to evaluate DBP. The following variables were considered in the research study: the number of inpatient days, the number of dressing changes, the level of pain experienced during dressing changes, and the condition of wounds at the time of the follow-up examination. Results: The research involved 68 participants. It was found that the patients who were treated with a DBP experienced less pain with less changes of dressings. However, the number of inpatient days and wound healing failed to demonstrate statistically significant difference compared to the control group. Conclusions: In the given research, DBP showed efficacy in improving patients’ quality of life by reducing pain and the number of dressings’ changes. However, when comparing this research study with the studies of other animal-derived wound coverings, there were a number of differences and limitations in the parameters. Thus, the results requires further study for a greater comparability of data. Given the above, we expect that DBP will become an inexpensive and effective treatment for burns in developing countries.

show abstract

Section: Introductionmentioning

confidence: 99%